Neurovigil, Inc.
NeuroVigil is a global neurotechnology pioneer which develops proprietary non-invasive brain monitors and advanced machine learning algorithms to detect a constellation of biomarkers of pathologies in asymptomatic individuals, such as people with neurodegeneration, adverse drug side effects or brain cancer, and to ascertain intent including, at the request of the late Dr. Stephen Hawking, in individuals who cannot otherwise communicate. This arsenal of technologies does not require any non-human animal experimentation. The company successfully went to market in 2009, garnered research contracts with elite pharmaceutical companies, and spearheads a growing international preventive health conglomerate of leading innovators and entrepreneurs.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Monitoring
- Market Focus:
- Globally (various continents)
About us
The SPEARS algorithm extracts high-resolution brain activity from non-invasive data and generates maps of hidden signals shared across humans and animals. The technology has made it possible for NeuroVigil to develop iBrain, the world’s first portable non-invasive brain monitor. The system is being used to detect, monitor treatment, and restore loss of function, such as communication, in a wide array of neurological diseases. Among those benefiting are autistic children, patients in clinical trials, disabled veterans, and ALS sufferers, including Stephen Hawking.